黄豆苷元

Daidzein

未知生产厂商

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

适应症

用于高血压病及症状性高血压，冠心病、心绞痛、心肌梗塞、脑血栓、眩晕病、突发性耳聋的辅助性治疗。也可用于妇女更年期综合症。

技术标识符

化学式: C₁₅H₁₀O₄
CAS 编号: 486-66-8
UNII ID: 6287WC5J2L

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Dietary supplements comprising soy hypocotyls containing at least one isoflavone
US 7045155 B2申请人: NOVOGEN RES PTY LTD优先权: 2000
US
9 件公开
COMBINATION OF PSICOSE AND DAIDZEIN AS A MEDICINAL AGENT
EP 3170502 B1申请人: CJ CHEILJEDANG CORP优先权: 2011
EP
US
6 件公开
Equol-producing lactic acid bacteria-containing composition
US 8765445 B2申请人: UCHIYAMA SHIGETO优先权: 2003
CN
US
5 件公开
EQUAL-CONTAINING FERMENTATION PRODUCT OF SOYBEAN EMBRYONIC AXIS, AND METHOD FOR PRODUCTION THEREOF
US 2009311353 A1申请人: OTSUKA PHARMA CO LTD优先权: 2005
CN
US
5 件公开
Daidzein analogs as treatment for cancer
US 8962679 B2申请人: WANG GUANGDI优先权: 2010
US
WO
5 件公开
Microbial method of making equol-containing composition and product made
US 7345089 B2申请人: OTSUKA PHARMA CO LTD优先权: 1997
US
5 件公开
ENHANCED OSTEOGENIC ACTIVITY OF DAIDZEIN ANALOGS ON HUMAN MESENCHYMAL STEM CELLS
EP 2981530 B1申请人: THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND优先权: 2013
EP
US
WO
4 件公开
Fermentation product containing equol-producing microorganism having maintained equol-producing ability, and method for producing same
US 9101159 B2申请人: ISONO YOSHIKAZU优先权: 2008
CN
US
4 件公开
DAIDZEIN DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT AND PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
EP 2789604 B1申请人: ANHUI BIOCHEM BIO PHARMACEUTICAL CO LTD优先权: 2011
EP
US
3 件公开
Composition and method for protecting skin from UV induced immunosuppression and skin damage
US 6455032 B1申请人: NOVOGEN RES PTY LTD优先权: 1997
US
3 件公开

药物